These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 6235871
1. Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrate. Gjerset GF, Martin PJ, Counts RB, Fast LD, Hansen JA. Blood; 1984 Sep; 64(3):715-20. PubMed ID: 6235871 [Abstract] [Full Text] [Related]
2. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. Menitove JE, Aster RH, Casper JT, Lauer SJ, Gottschall JL, Williams JE, Gill JC, Wheeler DV, Piaskowski V, Kirchner P, Montgomery RR. N Engl J Med; 1983 Jan 13; 308(2):83-6. PubMed ID: 6401196 [No Abstract] [Full Text] [Related]
3. Impaired cell-mediated immunity in patients with classic hemophilia. Lederman MM, Ratnoff OD, Scillian JJ, Jones PK, Schacter B. N Engl J Med; 1983 Jan 13; 308(2):79-83. PubMed ID: 6216408 [No Abstract] [Full Text] [Related]
4. Normal T-cell subset ratios in patients with severe haemophilia A treated with cryoprecipitate. Rasi VP, Koistinen JL, Lohman CM, Silvennoinen OJ. Lancet; 1984 Feb 25; 1(8374):461. PubMed ID: 6142197 [No Abstract] [Full Text] [Related]
5. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate. Tsoukas C, Gervais F, Fuks A, Guttmann RD, Strawczynski H, Shuster J, Gold P. Can Med Assoc J; 1983 Oct 01; 129(7):713-7. PubMed ID: 6225504 [Abstract] [Full Text] [Related]
6. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates. Lechner K, Niessner H, Bettelheim P, Deutsch E, Fasching I, Fuhrmann M, Hinterberger W, Korninger C, Neumann E, Liszka K. Thromb Haemost; 1983 Aug 30; 50(2):552-6. PubMed ID: 6314582 [Abstract] [Full Text] [Related]
14. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate. Smid WM, van der Meer J, Smit JW, Halie MR. Thromb Haemost; 1993 Apr 01; 69(4):306-10. PubMed ID: 8388579 [Abstract] [Full Text] [Related]
19. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage. Jason J, McDougal JS, Holman RC, Stein SF, Lawrence DN, Nicholson JK, Dixon G, Doxey M, Evatt BL. JAMA; 1985 Jun 21; 253(23):3409-15. PubMed ID: 2987559 [Abstract] [Full Text] [Related]
20. Abnormalities of lymphocyte subsets are correlated with concentrate consumption in asymptomatic Italian hemophiliacs treated with concentrates made from American plasma. Mannucci PM, Gringeri A, Ammassari M, Mari D. Am J Hematol; 1984 Aug 21; 17(2):167-76. PubMed ID: 6235744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]